-+ 0.00%
-+ 0.00%
-+ 0.00%

EXPEDITION THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $115 MILLION SERIES B FINANCING TO ADVANCE NEXT-GENERATION DPP1 INHIBITOR FOR COPD

Reuters·08/05/2026 12:01:12

Please log in to view news